A cancer diagnosis rarely arrives on a convenient schedule, and neither does the paperwork that follows it. Recent oversight reports have flagged a troubling pattern: some Medicare Advantage plans are delaying or denying newer, safer cancer treatments such as proton beam therapy, CAR T-cell therapy, and certain targeted drug therapies through prior authorization rules. This matters far more during enrollment or an annual plan review than after a diagnosis, when your options narrow quickly.
This article walks through what is happening, why it happens, and how you can compare plans clearly before you ever need cancer care. You do not need a medical or legal background to understand the differences. You just need the right information at the right time.
Key Takeaways
Prior authorization rules in Medicare Advantage can delay or deny newer cancer treatments that Original Medicare typically covers without extra approval steps. Medicare Advantage plans have an annual out-of-pocket maximum of $9,250 in 2026, but that limit only helps once you are inside the network and treatment is approved. The most protective step is comparing doctors, prescriptions, and treatment authorization policies before enrolling, ideally with a licensed agent who can walk through plan documents with you.
What Is Happening: Why Some Advantage Plans Are Denying Advanced Cancer Treatments
Prior authorization is a process where your plan must approve a treatment before it will pay for it. Your oncologist recommends a therapy, but instead of moving forward immediately, the request goes to the insurer for review. If the plan asks for more documentation, delays the decision, or denies the request outright, treatment can be pushed back at a time when speed matters most.
Several types of cancer care have drawn scrutiny under this process, including proton beam therapy for certain tumor types, CAR T-cell therapy for blood cancers, and newer targeted drug therapies that cost more than older chemotherapy regimens. This is not a rumor or a scare tactic. Oversight bodies, including the <a href="https://oig.hhs.gov/">HHS Office of Inspector General</a>, have documented patterns of Medicare Advantage plans denying requests that met Medicare coverage rules.
Documented Pattern
Federal oversight reviews have found instances where Medicare Advantage plans denied prior authorization requests that would have been approved under Original Medicare coverage criteria.
How Prior Authorization Rules Differ From Original Medicare
Original Medicare generally covers treatments your doctor deems medically necessary, following Medicare's national and local coverage rules, without requiring a separate approval step before care begins. Medicare Advantage plans, by contrast, are run by private insurers and can add layers of prior authorization for expensive or newer treatments. This difference is one of the most important things to understand before choosing between the two paths.
Key Takeaways
- Prior authorization rules in Medicare Advantage can delay or deny newer cancer treatments such as proton beam therapy, CAR T-cell therapy, and targeted drug therapies
- Original Medicare generally covers medically necessary treatments without requiring a separate approval step before care begins
- Federal oversight reviews, including those from the HHS Office of Inspector General, have found Medicare Advantage plans denying requests that would have been approved under Original Medicare
- Medicare Advantage plans have a $9,250 out-of-pocket maximum in 2026, but that protection only applies once treatment is approved and you are in network
- Comparing doctors, prescriptions, and treatment authorization policies before enrolling, ideally with a licensed agent, is the most protective step you can take
Why Medicare Terms and Plan Types Feel So Confusing When You're Comparing Cancer Coverage
An HMO plan generally requires you to choose a primary care doctor and get referrals to see specialists, including oncologists. A PPO plan offers more flexibility to see out-of-network providers, usually at a higher cost. Original Medicare, often paired with a Medigap supplement, lets you see any doctor or facility nationwide that accepts Medicare, with no network restrictions.
For cancer care specifically, these differences affect how quickly you can see a specialist and whether your plan requires authorization before starting treatment. An HMO may slow down access to a cancer center outside its network entirely. A PPO may allow it but at a steeper cost. Original Medicare with a supplement generally removes the network question altogether, though it does not eliminate Part D drug coverage rules.
None of this requires you to become a Medicare expert overnight. Understanding these differences is really about asking the right questions before you enroll, not memorizing insurance terminology.
The Fear of Choosing Wrong: What Happens If Your Plan Denies Treatment After Enrollment
Picture this scenario: a 68-year-old enrolled in a Medicare Advantage HMO receives a cancer diagnosis and her oncologist recommends a targeted drug therapy. The plan denies the prior authorization request, citing insufficient documentation. A denial letter arrives days later, right when she expected to start treatment.
At this point, she has the right to appeal. Medicare Advantage plans are required to offer an appeals process, and expedited appeals for urgent medical situations must typically be decided within 72 hours. Standard appeals can take longer, often up to 30 days for pre-service requests, which can feel unbearable during an active cancer diagnosis.
Switching plans is not always an immediate option either. Outside of specific enrollment periods, she may be locked into her current plan for the rest of the year, appeals process and all. This is the emotional weight many people carry: feeling stuck in a plan during the exact moment they need flexibility most.
Eddie's Pro Tip
I always tell people to ask about prior authorization policies before they need cancer treatment, not after. Pull up your plan's specific coverage criteria for high-cost therapies during your annual review, even if you feel perfectly healthy. It takes ten minutes now and can save you weeks of stress later.
Uncertainty About Costs: What Cancer Treatment Really Costs Under Different Medicare Options
Cancer treatment costs vary widely depending on which Medicare path you choose. Under Original Medicare with a Medigap supplement, most out-of-pocket costs for chemotherapy and radiation are covered after you meet your Part B deductible of $283 in 2026, since Medigap plans are designed to cover the coinsurance gaps. Under Medicare Advantage, you typically pay copays or coinsurance for each service until you reach your plan's annual out-of-pocket maximum, which is capped at $9,250 in 2026.
| Coverage Type | How Costs Work | 2026 Key Figure |
|---|---|---|
| Original Medicare + Medigap | Part B deductible met, then Medigap covers coinsurance | $283 Part B deductible |
| Medicare Advantage | Copays/coinsurance per service until MOOP is reached | $9,250 maximum out-of-pocket |
| Part D (Drug Coverage) | Deductible, then tiered copays until catastrophic phase | $615 max deductible, $2,100 catastrophic threshold |
Actual costs depend on the specific plan you choose and the treatments you need.
Newer oral cancer therapies are covered through Part D rather than Part B, which adds another layer of cost to track. In 2026, Part D plans can have a deductible as high as $615, and once you reach the catastrophic phase threshold of $2,100 in total drug costs, your out-of-pocket spending drops significantly. Specialist visit copays and outpatient treatment fees under Medicare Advantage can add up fast during active treatment, even before you hit your annual maximum.
Know Your Numbers
The 2026 Medicare Advantage out-of-pocket maximum is $9,250, but that cap only applies to in-network care. Out-of-network costs under a PPO are not included in that limit.
Will Your Oncologist and Cancer Center Be Covered? Checking Doctor and Facility Access
Confirming that your preferred oncologist and cancer center are in-network should happen before you enroll, not after you receive a diagnosis. Specialty cancer treatment often happens at specific centers with advanced equipment, like proton beam therapy facilities, and not every plan network includes them.
You can check network status directly through a plan's provider directory, but these directories are not always accurate or current. Calling the cancer center's billing office and asking which Medicare Advantage plans they accept is often more reliable. A licensed agent can also help you cross-reference this information against multiple plans at once, saving you the trouble of calling several offices yourself.
One risk worth understanding: narrow networks can change mid-year. A cancer center that was in-network in January is not guaranteed to remain in-network in December. Medicare Advantage plans are required to notify members of network changes, but the timing does not always align conveniently with active treatment schedules.
Prescription Coverage: Making Sure Cancer Medications Are on Your Plan's Formulary
Oral chemotherapy and targeted cancer drugs are placed into specific tiers on a plan's drug formulary, and tier placement directly affects your copay. A drug in a lower tier might cost you a modest copay, while the same type of drug placed in a higher specialty tier can carry a much steeper cost share, sometimes a percentage of the drug's total price rather than a flat fee.
Checking formulary coverage should happen before you enroll, especially if you have a family history of cancer or an existing diagnosis that may require ongoing medication. Ask specifically whether the drug is covered, what tier it falls into, and whether prior authorization is required for that specific medication.
Formularies are not static. Plans can and do change their drug lists annually, sometimes moving a medication to a higher tier or removing it entirely. Reviewing your plan's formulary every year during Annual Enrollment protects you from a mid-year surprise on a medication you rely on.
Enrollment Timing: Why Acting During the Right Window Protects Your Cancer Care Options
Reviewing or switching Medicare coverage happens during specific windows, and missing one can mean staying locked into a plan with treatment restrictions for months. The Annual Enrollment Period runs from October 15 to December 7 each year, allowing you to switch between Medicare Advantage plans, move to Original Medicare, or change your Part D coverage.
The Medicare Advantage Open Enrollment Period runs January 1 to March 31 and allows a one-time switch if you are already enrolled in a Medicare Advantage plan and want to change plans or move to Original Medicare. Outside these windows, your options to change coverage are limited unless you qualify for a Special Enrollment Period.</p>
Timing Matters
Missing the Annual Enrollment window means waiting until the next cycle to switch plans in most cases, even if you discover mid-year that your plan restricts a treatment you need.
This is exactly why reviewing your coverage now, whether you are approaching 65 or simply revisiting an existing plan, matters more than waiting until a health concern arises. Acting during the right window, while you are healthy, gives you far more control than trying to make a decision during an active diagnosis.
How to Compare Plans With Confidence Before You Ever Need Cancer Treatment
A clear comparison process starts with your doctors, your prescriptions, and your realistic expectations for future care needs, not just the monthly premium. From there, look at total costs, including deductibles, copays, and out-of-pocket maximums, since a lower premium can sometimes mean higher costs if you ever need active treatment.
List your current doctors and any specialists you may need, including oncologists or cancer centers.
Check your current or prospective medications against each plan's formulary and tier placement.
Compare out-of-pocket maximums and prior authorization policies for high-cost treatments.
Review total annual costs, not just the monthly premium, across the plans you are considering.
Ask a licensed agent to confirm your understanding before you enroll or make a change.
Licensed Medicare agents can walk through plan documents and coverage details with you at no cost, without pressure to decide on the spot. Comparing options while you are healthy is far easier than trying to sort through plan language during a diagnosis, when time and energy are already stretched thin.
Frequently Asked Questions
I'm not ready to talk to anyone yet. Can I just research this on my own first?
Will I get a pushy sales call if I ask about plan comparisons?
Can I really figure out cancer treatment coverage on my own by reading plan documents?
How do I know which sources about Medicare and cancer coverage I can trust?
What if I choose a plan now and regret it later if I need cancer treatment?
Does every Medicare Advantage plan deny newer cancer treatments?
Conclusion
Understanding how Medicare Advantage plans differ from Original Medicare, particularly around prior authorization for cancer treatment, protects your access to care long before you ever need it. Reviewing your doctors, prescriptions, and true costs now gives you far more control than trying to sort through plan language during a health crisis.
When you are ready, comparing options with a licensed agent costs nothing and comes with no obligation to enroll. Clear, judgment-free guidance can help you choose coverage that protects the care you may need down the road.
Related Articles
Have Medicare questions?
Our licensed Medicare agents are available to help you find the right coverage.